share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

西维斯健康 | 4:持股变动声明-高管 Mandadi Tilak
美股SEC公告 ·  09/03 17:51

Moomoo AI 已提取核心信息

On August 31, 2024, CVS Health Corp's EVP and Chief Technology Officer, Mandadi Tilak, completed a sale of 13,097 shares of common stock at a price of $57.24 per share. The transaction, which was carried out under the transaction code 'F' indicating a payment of exercise price or tax liability by delivering or withholding securities, resulted in a total market value of $749,672.28. Following the sale, Tilak's direct holdings in CVS Health Corp amounted to 40,414 shares.
On August 31, 2024, CVS Health Corp's EVP and Chief Technology Officer, Mandadi Tilak, completed a sale of 13,097 shares of common stock at a price of $57.24 per share. The transaction, which was carried out under the transaction code 'F' indicating a payment of exercise price or tax liability by delivering or withholding securities, resulted in a total market value of $749,672.28. Following the sale, Tilak's direct holdings in CVS Health Corp amounted to 40,414 shares.
2024年8月31日,CVS Health Corp的执行副总裁兼首席技术官Mandadi Tilak以57.24美元每股的价格完成了13097股普通股的出售。这笔交易是在交易代码'F'下进行的,表示通过交付或扣留证券支付行权价格或税款,导致总市场价值为749,672.28美元。在此次出售后,Tilak对CVS Health Corp的直接持股为40,414股。
2024年8月31日,CVS Health Corp的执行副总裁兼首席技术官Mandadi Tilak以57.24美元每股的价格完成了13097股普通股的出售。这笔交易是在交易代码'F'下进行的,表示通过交付或扣留证券支付行权价格或税款,导致总市场价值为749,672.28美元。在此次出售后,Tilak对CVS Health Corp的直接持股为40,414股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息